Effect of treating psoriasis on cardiovascular co-morbidities: focus on TNF inhibitors. - Wikidata - awgldk - TriplyDB

Effect of treating psoriasis on cardiovascular co-morbidities: focus on TNF inhibitors.

Effect of treating psoriasis on cardiovascular co-morbidities: focus on TNF inhibitors.

http://www.wikidata.org/entity/Q38166661

about

Most common dermatologic topics published in five high-impact general medical journals, 1970-2012: melanoma, psoriasis, herpes simplex, herpes zoster, and acne.Psoriasis and comorbidities: links and risks.Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry Adalimumab: A Review in Chronic Plaque Psoriasis.Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations.Do Biologics Protect Patients With Psoriasis From Myocardial Infarction? A Retrospective Cohort.IL-17 Blockade in Psoriasis: Friend or Foe in Cardiovascular Risk?Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.Psoriasis and inflammatory bowel disease: links and risks.Factors influencing cardiometabolic risk profile in patients with psoriasis.Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization

P2860

Q34386659-C86D3090-08C8-464C-AE17-F22503D74297 Q34418506-2AA24975-0882-4C37-A6DB-564FB6150D02 Q38372071-88F22F28-AF07-42DA-86C6-6B645C8E3C95 Q38639495-42E19F6E-FC90-401A-B2C0-E9E395F98EA3 Q38935290-6EF059CF-7B99-44D6-801F-56C8AD261980 Q40743693-1E02B961-AFEE-4178-BABA-9D86F8A59C34 Q41104626-45486A0A-42E9-4CFE-9E4A-92614D3FD300 Q46180528-1ED46BF8-E9F1-49B7-9A6F-815E905A6C8A Q52859380-D2217953-7D45-4B63-9011-11D01B566569 Q53749532-FA30C0F5-1BBA-4CCA-9742-0B1305B8BA36 Q55515872-3F7A9BD1-C330-41DC-931E-77979B8A7604

P2860

Effect of treating psoriasis on cardiovascular co-morbidities: focus on TNF inhibitors.

http://www.wikidata.org/entity/Q38166661

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Effect of treating psoriasis on cardiovascular co-morbidities: focus on TNF inhibitors.

@en

type

label

Effect of treating psoriasis on cardiovascular co-morbidities: focus on TNF inhibitors.

@en

prefLabel

Effect of treating psoriasis on cardiovascular co-morbidities: focus on TNF inhibitors.

@en

P1433

Q38166661-CFC29A92-5750-48DF-B0FE-98522B18D922

P1476

Q38166661-D2234362-E57D-407A-9DC7-5F5C2BED67F6

P2093

Q38166661-101C23AF-4AC4-439D-86A0-CE5B429D5194

Q38166661-469BD68E-9963-4541-A622-8C3FA433E0E5

P2860

Q38166661-10E2EEAC-8B90-41C1-B9CF-9A2F108A1092

Q38166661-12292AF1-A228-4D96-8F41-DB4DE65DE44D

Q38166661-26C3B028-AA2D-41EC-BAF2-BBCD4E0FFD05

Q38166661-26E0712F-7F46-4F0E-A567-69C9AE62A069

Q38166661-399BB364-3018-452E-B61C-910900BFC0C7

Q38166661-3C98C81D-EAAC-4558-AEF3-404E6F71FDE2

Q38166661-4C2A757F-A673-4672-98F6-4521EC204937

Q38166661-5939B4ED-5E00-497F-90AB-6FB73A531D30

Q38166661-5DD7F133-A40E-4045-98CD-87A282EEFD3C

Q38166661-5E41AE02-06A2-4934-9A00-D3482AA72BFA

P2888

Q38166661-DA88CB8E-38AD-4DE9-BE41-9200067CB163

P304

Q38166661-8E7787F9-8934-47A3-9493-F2428FB44810

P31

Q38166661-588E3452-8C99-40BC-9E60-F2B72031A7F8

P356

Q38166661-21288516-898E-4D90-B8A2-A3426E300219

P433

Q38166661-5EB01B0C-7984-4734-B514-75545C46D308

P478

Q38166661-264302C5-9F8C-47A6-A019-0D2320DCD00C

P50

Q38166661-22315422-9966-4256-90EE-38B7C5138604

P577

Q38166661-0994EC3D-0111-400D-9EFD-200A9487C946

P6179

Q38166661-A8D04FE7-8377-4900-BB1F-460131D9CEE7

P698

Q38166661-EFF7E6F0-6ECB-4DBF-BF10-6ADBFE6B6AB0

P921

Q38166661-3E3288AE-AA18-4077-BA4C-FA4B04020756

P356

S40257-013-0052-6

P1433

American Journal of Clinical Dermatology

P1476

Effect of treating psoriasis on cardiovascular co-morbidities: focus on TNF inhibitors.

@en

P2093

Eric Y Sako

http://www.w3.org/2001/XMLSchema#string

Shannon Famenini

http://www.w3.org/2001/XMLSchema#string

P2860

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database.

Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives.

Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.

The association of psoriasis and elevated blood lipids in overweight and obese children.

The role of tumor necrosis factor-α and TNF-α receptors in cerebral arteries following cerebral ischemia in rat

Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.

Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy.

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance

Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs

Psoriasis and new-onset diabetes: a Danish nationwide cohort study

P2888

s40257-013-0052-6

P304

45-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40257-013-0052-6

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1006019566

http://www.w3.org/2001/XMLSchema#string

P698

24281789

http://www.w3.org/2001/XMLSchema#string

P921